Bertrand William C JR's Form 4 filing
Adaptimmune Therapeutics PLC (ADAPY) · filed Jan 17, 2023
- Accession no.
- 0001104659-23-004381
- Filed
- Jan 17, 2023
- Trade date
- Jan 17, 2023
- Filing delay
- Same day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market sales total $8.26K. It was filed on the trade date.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Bertrand William C JRCIK 0001291937 | Officer (Chief Operating Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 17, 2023 | American Depositary Shares representing Ordinary Shares | SSaleDisposed | −4,440 | $1.86 | −$8,258.4 | 7,264 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.